Kitzen JJ - Search Results

1

Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.

Engels FK, de Jong FA, Sparreboom A, Mathot RA, Loos WJ, Kitzen JJ, de Bruijn P, Verweij J, Mathijssen RH. Engels FK, et al. Among authors: kitzen jj. Oncologist. 2007 Mar;12(3):291-300. doi: 10.1634/theoncologist.12-3-291. Oncologist. 2007. PMID: 17405893 Free article.

2

Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drain.

de Jong FA, Kitzen JJ, de Bruijn P, Verweij J, Loos WJ. de Jong FA, et al. Among authors: kitzen jj. Cancer Biol Ther. 2006 Sep;5(9):1105-10. doi: 10.4161/cbt.5.9.3294. Epub 2006 Sep 19. Cancer Biol Ther. 2006. PMID: 16969123

3

Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity.

de Jong FA, van der Bol JM, Mathijssen RH, Loos WJ, Mathôt RA, Kitzen JJ, van den Bent MJ, Verweij J. de Jong FA, et al. Among authors: kitzen jj. Cancer Biol Ther. 2007 Sep;6(9):1368-74. doi: 10.4161/cbt.6.9.4567. Epub 2007 Jun 13. Cancer Biol Ther. 2007. PMID: 17873515

4

A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.

Attard G, Kitzen J, Blagden SP, Fong PC, Pronk LC, Zhi J, Zugmaier G, Verweij J, de Bono JS, de Jonge M. Attard G, et al. Br J Cancer. 2007 Nov 19;97(10):1338-43. doi: 10.1038/sj.bjc.6604043. Epub 2007 Nov 13. Br J Cancer. 2007. PMID: 18000498 Free PMC article. Clinical Trial.

5

The relevance of microdialysis for clinical on:cology.

Kitzen JJ, Verweij J, Wiemer EA, Loos WJ. Kitzen JJ, et al. Curr Clin Pharmacol. 2006 Sep;1(3):255-63. doi: 10.2174/157488406778249316. Curr Clin Pharmacol. 2006. PMID: 18666750 Review.

6

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours.

Kitzen JJ, de Jonge MJ, Lamers CH, Eskens FA, van der Biessen D, van Doorn L, Ter Steeg J, Brandely M, Puozzo Ch, Verweij J. Kitzen JJ, et al. Eur J Cancer. 2009 Jul;45(10):1764-72. doi: 10.1016/j.ejca.2009.01.026. Epub 2009 Feb 27. Eur J Cancer. 2009. PMID: 19251409 Clinical Trial.

7

Aurora kinase inhibitors.

Kitzen JJ, de Jonge MJ, Verweij J. Kitzen JJ, et al. Crit Rev Oncol Hematol. 2010 Feb;73(2):99-110. doi: 10.1016/j.critrevonc.2009.03.009. Epub 2009 Apr 14. Crit Rev Oncol Hematol. 2010. PMID: 19369091 Review.

8

Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.

Baird RD, Kitzen J, Clarke PA, Planting A, Reade S, Reid A, Welsh L, López Lázaro L, de las Heras B, Judson IR, Kaye SB, Eskens F, Workman P, deBono JS, Verweij J. Baird RD, et al. Mol Cancer Ther. 2009 Jun;8(6):1430-7. doi: 10.1158/1535-7163.MCT-08-1167. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509256 Clinical Trial.

9

Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic study.

Kitzen JJ, Puozzo C, de Jonge MJ, Brandely M, Verweij J. Kitzen JJ, et al. Eur J Cancer. 2010 Jan;46(2):266-9. doi: 10.1016/j.ejca.2009.10.031. Epub 2009 Nov 26. Eur J Cancer. 2010. PMID: 19944596 Clinical Trial.

10

Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours.

de Jonge MJ, Dumez H, Kitzen JJ, Beuselinck B, Verweij J, Courtney R, Battista A, Brega N, Schöffski P. de Jonge MJ, et al. Among authors: kitzen jj. Eur J Cancer. 2011 Jun;47(9):1328-35. doi: 10.1016/j.ejca.2011.02.012. Epub 2011 Mar 23. Eur J Cancer. 2011. PMID: 21439816 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page